Amanda Goodwin

Amanda Goodwin possesses extensive experience in global regulatory strategy, particularly within the neurology sector, having served in various leadership roles at Eisai US since October 2010. Progressing from Associate Director to Vice President, Amanda has expertly managed the filing and approval processes for Marketing Authorization Applications across multiple regions, including Australia, Canada, the EU, New Zealand, Switzerland, and the US. Responsibilities include developing regulatory strategies, leading product teams, and serving as the primary contact with Health Authorities. Prior experience as Regulatory Affairs Manager at The Medicines Company involved oversight for an intravenous antihypertensive across several countries. Amanda holds a degree in Management/Marketing from the University of South Australia.